John Harlow

CCO at Melinta Therapeutics

Speaker

John has served as Chief Commercial Officer at Melinta Therapeutics since March 2021 where he leads the commercial and corporate transformation to diversify the business to become a high-performing, Acute Care/Hospital Ecosystem pharma company. Delivering 30% revenue growth in 2022 leading a commercial team with ~80 FTEs across Marketing, Sales, Market Access, Trade, Training, Analytics, and Operations, John has prioritized profitability through operational excellence, eliminating redundancies, re-deploying resources from underperforming operations and through enhancing execution. John Harlow has a successful 20+ year history in healthcare working across multiple disciplines and therapeutic areas at large, mid-size and start-up pharma and biotech companies including Pfizer, Novartis, Alpharma, Shionogi and now Melinta Therapeutics where he serves as Chief Commercial Officer